适体
乳腺癌
医学
免疫原性
癌症
内科学
免疫学
免疫系统
生物
遗传学
作者
Rui Fan,Xufeng Tao,Xuguang Zhai,Yanna Zhu,Yunming Li,Yanwei Chen,Deshi Dong,Shilei Yang,Lei Lv
标识
DOI:10.1016/j.biopha.2023.114444
摘要
Despite significant treatment advances, breast cancer remains the leading cause of cancer death in women. From the current treatment situation, in addition to developing chemoresistant tumours, distant organ metastasis, and recurrences, patients with breast cancer often have a poor prognosis. Aptamers as "chemical antibodies" may be a way to resolve this dilemma. Aptamers are single-stranded, non-coding oligonucleotides (DNA or RNA), resulting their many advantages, including stability for long-term storage, simplicity of synthesis and function, and low immunogenicity, a high degree of specificity and antidote. Aptamers have gained popularity as a method for diagnosing and treating specific tumors in recent years. This article introduces the application of ten different aptamer delivery systems in the treatment and diagnosis of breast cancer, and systematically reviews their latest research progress in breast cancer treatment and diagnosis. It provides a new direction for the clinical treatment of breast cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI